Feline cystatin C antibody and antigen (recombinant protein)
Diagnostic anti-Feline cystatin C antibodies pairs and antigen for animal health (animal Cat/Feline Hormone disorders) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Neurodegenerative diseases diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-FEL-CysC-Ag01 | Recombinant Feline cystatin C protein | 3090 |
GMP-FEL-CysC-Ab01 | Anti-Feline cystatin C mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-CysC-Ab02 | Anti-Feline cystatin C mouse monoclonal antibody (mAb) | 1953 |
GMP-FEL-CysC-Ab03 | Anti-Feline cystatin C human monoclonal antibody (mAb) | 1953 |
GMP-FEL-CysC-Ab04 | Anti-Feline cystatin C human monoclonal antibody (mAb) | 1953 |
Size: 1mg | 10mg | 100mg
Product Description
Cat No. of Products | GMP-FEL-CysC-Ag01 |
Product Name | Recombinant Feline cystatin C protein |
Target/Biomarker | Feline Cystatin C (CysC) |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Feline Cystatin C antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in CysC level test of animal Cat/Feline with Hormone disorders. |
Tag | His |
Products description | Recombinant Feline cystatin C protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-CysC-Ab01, GMP-FEL-CysC-Ab02 |
Product Name | Anti-Feline cystatin C mouse monoclonal antibody (mAb) |
Target/Biomarker | Feline Cystatin C (CysC) |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Feline Cystatin C antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies in CysC level test of animal Cat/Feline with Hormone disorders. |
Tag | mFc |
Products description | Anti-Feline cystatin C mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-FEL-CysC-Ab03, GMP-FEL-CysC-Ab04 |
Product Name | Anti-Feline cystatin C human monoclonal antibody (mAb) |
Target/Biomarker | Feline Cystatin C (CysC) |
Expression platform | CHO |
Isotypes | Human IgG1 |
Bioactivity validation | Recombinant Feline Cystatin C antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies in CysC level test of animal Cat/Feline with Hormone disorders. |
Tag | hFc |
Products description | Anti-Feline cystatin C human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-CysC antibodies. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Feline CYSC, or Cystatin C, is a modest-sized protein with outsized significance in the realm of feline health. This unassuming biomarker operates as a sentinel, a vigilant guardian of the intricate machinery within a cat's body, specifically, the renal system. Produced by cells throughout a cat's body at a consistent rate, Feline CYSC embarks on a journey that ultimately evaluates the health of the feline kidneys. Its voyage begins with the glomeruli, the intricate filtration units within the kidneys. Here, Feline CYSC is freely filtered from the blood, marking the initial step in assessing renal function. After traversing the glomeruli, Feline CYSC continues its odyssey through the renal tubules. Its fate is determined by the efficiency of glomerular filtration. In healthy cats, the majority of CYSC is reabsorbed and subsequently catabolized by the tubules. This intricate process ensures that CYSC levels in the bloodstream remain relatively stable, mirroring the efficiency of glomerular filtration. Feline CYSC's true strength lies in its sensitivity and specificity as a biomarker for renal health. Unlike traditional markers like creatinine, which can be influenced by variables such as muscle mass or diet, CYSC remains relatively immune to these factors. This makes CYSC a precise yardstick for evaluating renal function, especially in the early stages of kidney disease. Feline CYSC is the harbinger of proactive healthcare. Its ability to detect subtle shifts in renal function, even before overt clinical symptoms manifest, makes it an invaluable tool. Regular monitoring of CYSC levels can unveil renal issues in their infancy, allowing for timely intervention and a higher likelihood of successful treatment.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.